SLC2A1

SLC2A1 Full Name

solute carrier family 2 (facilitated glucose transporter), member 1

SLC2A1 Introduction

Introduction
The SLC2A1 (solute carrier family 2 member 1) gene encodes GLUT1 (glucose transporter 1), the first glucose transporter to be characterized and a fundamental protein responsible for mediating basal glucose uptake across plasma membranes in virtually all mammalian cells. As a member of the glucose transporter family, GLUT1 ensures the constant supply of glucose required for cellular respiration and energy metabolism. This gene has garnered extensive clinical and research attention due to its critical role in brain energy supply, its association with a spectrum of neurological disorders when mutated, and its emerging significance as a biomarker in cancer metabolism and immunotherapy response.

Figure 1. Strcuture of SLC2A1.

Protein Structure and Transport Mechanism
GLUT1 is a 55 kilodalton integral membrane protein that adopts a characteristic structure essential for its function as a uniporter. The protein contains 12 membrane-spanning alpha helices, each composed of approximately 20 amino acid residues that traverse the lipid bilayer. These helices are amphipathic—they contain both polar and hydrophobic faces—allowing them to assemble in the membrane to create a hydrophilic channel through which glucose can pass while the hydrophobic regions interact with the fatty acid tails of the membrane phospholipids. The transport mechanism follows Michaelis-Menten kinetics, facilitating glucose movement down its concentration gradient without energy expenditure. GLUT1 behaves as a passive carrier, binding glucose on one side of the membrane, undergoing a conformational change, and releasing glucose on the opposite side. This facilitated diffusion enables glucose entry into erythrocytes at a rate approximately 50,000 times greater than uncatalyzed transmembrane diffusion. The transporter exhibits broad substrate specificity, accommodating a wide range of aldoses including both pentoses and hexoses.

Conclusion

SLC2A1 encodes GLUT1, the archetypal glucose transporter that serves as the primary gateway for glucose entry into most human cells. From its essential role in brain energy supply to its pathological upregulation in cancer and its mutation in devastating neurological disorders, this gene exemplifies the fundamental importance of nutrient transport in health and disease. The clinical spectrum associated with SLC2A1 dysfunction—ranging from GLUT1 deficiency syndrome in children to cancer progression and immunotherapy resistance in adults—highlights the diverse consequences of perturbed glucose homeostasis. As both a therapeutic target in oncology and a diagnostic marker in neurology, SLC2A1 continues to drive research aimed at understanding metabolic regulation and developing interventions to correct its dysfunction.

Alternate Names for SLC2A1

SLC2A1; solute carrier family 2 (facilitated glucose transporter), member 1; GTG1; Gtg3; GLUTB; Glut1; RATGTG1; solute carrier family 2, facilitated glucose transporter member 1; GLUT-1; solute carrier family 2, member 1

• Immunohistochemistry Antibodies for Pathology